Yasir B. Al-wakeel - Net Worth and Insider Trading
Yasir B. Al-wakeel Net Worth
The estimated net worth of Yasir B. Al-wakeel is at least $353,024 dollars as of 2024-05-11. Yasir B. Al-wakeel is the CFO of Kronos Bio Inc and owns about 346,102 shares of Kronos Bio Inc (KRON) stock worth over $353,024. Details can be seen in Yasir B. Al-wakeel's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Yasir B. Al-wakeel has not made any transactions after 2023-07-06 and currently still holds the listed stock(s).
Transaction Summary of Yasir B. Al-wakeel
Yasir B. Al-wakeel Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Yasir B. Al-wakeel owns 4 companies in total, including Kronos Bio Inc (KRON) , Neon Therapeutics Inc (NTGN) , and Merrimack Pharmaceuticals Inc (MACK) among others .
Click here to see the complete history of Yasir B. Al-wakeel’s form 4 insider trades.
Insider Ownership Summary of Yasir B. Al-wakeel
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
KRON | Kronos Bio Inc | 2023-07-06 | Chief Financial Officer |
NTGN | Neon Therapeutics Inc | 2020-05-06 | Chief Financial Officer |
MACK | Merrimack Pharmaceuticals Inc | 2015-08-11 | CFO and Head of Corp Dev |
2021-07-29 | director |
Yasir B. Al-wakeel Latest Holdings Summary
Yasir B. Al-wakeel currently owns a total of 1 stock. Yasir B. Al-wakeel owns 346,102 shares of Kronos Bio Inc (KRON) as of July 6, 2023, with a value of $353,024.
Latest Holdings of Yasir B. Al-wakeel
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
KRON | Kronos Bio Inc | 2023-07-06 | 346,102 | 1.02 | 353,024 |
Holding Weightings of Yasir B. Al-wakeel
Yasir B. Al-wakeel Form 4 Trading Tracker
According to the SEC Form 4 filings, Yasir B. Al-wakeel has made a total of 3 transactions in Kronos Bio Inc (KRON) over the past 5 years, including 1 buys and 2 sells. The most-recent trade in Kronos Bio Inc is the sale of 9,617 shares on July 6, 2023, which brought Yasir B. Al-wakeel around $16,830.
Insider Trading History of Yasir B. Al-wakeel
- 1
Yasir B. Al-wakeel Trading Performance
GuruFocus tracks the stock performance after each of Yasir B. Al-wakeel's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Yasir B. Al-wakeel is 1.24%. GuruFocus also compares Yasir B. Al-wakeel's trading performance to market benchmark return within the same time period. The performance of stocks bought by Yasir B. Al-wakeel within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Yasir B. Al-wakeel's insider trading performs compared to the benchmark.
Performance of Yasir B. Al-wakeel
Yasir B. Al-wakeel Ownership Network
Ownership Network List of Yasir B. Al-wakeel
Ownership Network Relation of Yasir B. Al-wakeel
Yasir B. Al-wakeel Owned Company Details
What does Kronos Bio Inc do?
Who are the key executives at Kronos Bio Inc?
Yasir B. Al-wakeel is the Chief Financial Officer of Kronos Bio Inc. Other key executives at Kronos Bio Inc include COO & General Counsel Barbara Kosacz , Chief Scientific Officer Christopher Dinsmore , and Chief Medical Officer & VP Jorge Dimartino .
Kronos Bio Inc (KRON) Insider Trades Summary
Over the past 18 months, Yasir B. Al-wakeel made 2 insider transaction in Kronos Bio Inc (KRON) with a net sale of 18,643. Other recent insider transactions involving Kronos Bio Inc (KRON) include a net sale of 69,004 shares made by Jorge Dimartino , a net sale of 39,461 shares made by Christopher Dinsmore , and a net purchase of 1,731,056 shares made by Norbert W Bischofberger .
In summary, during the past 3 months, insiders sold 31,509 shares of Kronos Bio Inc (KRON) in total and bought 0 shares, with a net sale of 31,509 shares. During the past 18 months, 169,293 shares of Kronos Bio Inc (KRON) were sold and 1,731,056 shares were bought by its insiders, resulting in a net purchase of 1,561,763 shares.
Kronos Bio Inc (KRON)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kronos Bio Inc Insider Transactions
Yasir B. Al-wakeel Mailing Address
Above is the net worth, insider trading, and ownership report for Yasir B. Al-wakeel. You might contact Yasir B. Al-wakeel via mailing address: Merrimack Pharmaceuticals, Inc., One Kendall Square, Suite B7201, Cambridge Ma 02139.